Then, seven genes, including BMP2, GSTA1, GSTA3, BST1, S100A9, TTR, and GATM, were identified as the targets of the YSHS granule in the treatment of ADR-induced FSGS by Real-time PCR analysis. The gene discussed is GSTA3; the disease is focal segmental glomerulosclerosis.